Loading
Life sciences · Journal article
Medical Science Monitor · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Advances in cancer treatment, particularly platinum-based chemotherapy and radiotherapy, have substantially improved patient survival.However, these therapies carry a risk of serious adverse effects, including ototoxicity that can cause permanent hearing loss.This narrative review surveys the scientific literature regarding hearing impairment among oncology patients of various ages who received chemotherapy and/or radiotherapy.Treatment with cytotoxic drugs, particularly cisplatin, and radiotherapy to the head and neck are associated with a high risk of bilateral, high-frequency, permanent, and progressive hearing loss.Risk factors include cumulative drug dose, patient age, comorbidities, and previous ototoxic treatment.A comprehensive audiological monitoring protocol should be established before, during, and after cancer treatment.Important considerations include baseline hearing assessment, regular audiological monitoring, age-appropriate behavioral audiometry, and objective auditory measures, such as otoacoustic emissions.Therapies based on identification of genetic markers represent a promising development that may minimize adverse effects and improve quality of life among patients with cancer.This article examines the effects of cancer treatment on the auditory system and evaluates current approaches to the prevention, diagnosis, and management of ototoxicity.It also provides standardized recommendations for audiological monitoring of patients with cancer.